NCT06423612 - Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING PUMA) | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

May 8, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions

ART Adherence

Interventions

BEHAVIORAL

POC urine assay informed enhanced ART adherence counselling for viral suppression

Collect urine on intervention participants and screen for presence of TFV. Feedback will be provided to the participant based on the results on their ART adherence with provision of enhanced ART adherence counseling for viral suppression.

Trial Locations (1)

Unknown

RECRUITING

Desmond Tutu HIV Foundation, East London

All Listed Sponsors

collaborator

Desmond Tutu HIV Foundation

OTHER

collaborator

University of Cape Town

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of California, San Francisco

OTHER